Tirzepatide will challenge a number of established dogmas in diabetology, and hopefully will make the lives of patients with type 2 diabetes easier and longer
Semaglutide activates GLP-1 receptors only, while tirzepatide is a dual GIP/GLP-1 receptor agonist, activating two complementary pathways involved in blood sugar regulation and appetite control
20% was the highest concentration available
Lyophilised powder tolerates up to three freeze-thaw cycles before significant degradation occurs because water content is below 3%
As the GLP-1 drug market continues to evolve, the balance between accessibility, safety, and regulatory oversight will be key
Long-term Health Benefits Beyond immediate weight loss, the combination of Semaglutide and B6 offers long-term health benefits